Yes, COVID-19 still exists and continues to circulate worldwide. The virus never disappeared. What changed is its status: the U.S. federal public health emergency ended on May 11, 2023, and the WHO declared an end to COVID-19 as a global health emergency around the same time. But the end of emergency declarations was never a statement that the virus was gone. It meant the crisis phase was over, not the virus itself.
How COVID-19 Is Tracked Now
Because most countries stopped requiring widespread testing, the old metrics of daily case counts no longer exist. In the U.S., the CDC shifted to other surveillance tools. The most reliable is wastewater monitoring, which measures how much virus is present in sewage systems across the country. As of late February 2026, the national wastewater viral activity level for COVID-19 was moderate. This system doesn’t depend on people getting tested or reporting results, so it captures a more honest picture of how much virus is actually out there.
Hospital admissions are still tracked, though reporting shifted from daily to weekly after the emergency ended. Emergency department visits with diagnosed COVID-19 are also reported weekly. Individual case counts and county-level testing data, however, were removed from the CDC’s main tracker. Deaths are now reported through the National Vital Statistics System, with a weekly metric showing the percentage of all deaths that are COVID-associated.
The Virus Keeps Changing
SARS-CoV-2 continues to mutate, producing new variants and sublineages. As of mid-February 2026, the CDC’s variant tracking showed a diverse mix of circulating strains. The XFG lineage and its subvariants made up the largest share, with XFG alone accounting for roughly 29% of sequenced samples. NB.1.8.1 followed at about 21%, and XFG.2.5.1 at 16%. Several other lineages each represented smaller fractions. This constant turnover is why vaccine formulas are updated regularly, similar to the annual flu shot.
The FDA advised manufacturers that COVID-19 vaccines for fall 2025 onward should target a JN.1-lineage composition, preferentially using a strain called LP.8.1, to better match what’s actually circulating. This annual update cycle is now a permanent feature of COVID-19 prevention.
Who Still Gets Seriously Ill
For most people, a COVID-19 infection in 2026 is milder than it was in 2020 or 2021. Widespread immunity from vaccination, prior infection, or both has blunted the virus’s ability to cause severe disease across the population. But it still hospitalizes and kills people, particularly those in higher-risk groups.
The main risk factors for severe illness include being over 65 (with risk climbing sharply past 75), being unvaccinated or behind on recommended boosters, having multiple chronic health conditions, and being immunocompromised. Residents of long-term care facilities also face elevated risk. For people outside these groups, COVID-19 typically presents as a cold or flu-like illness that resolves on its own.
Treatment Still Available
Antiviral treatments remain available for people at higher risk. Paxlovid (nirmatrelvir-ritonavir) is the first-line option for adults and children 12 and older who weigh at least 88 pounds. Molnupiravir serves as an alternative when Paxlovid isn’t suitable. Both are oral medications taken for five days, and both need to be started within five days of symptom onset to be effective. The key is acting quickly: if you’re in a high-risk group and test positive, contacting a healthcare provider the same day gives you the best chance of benefiting from treatment.
Long COVID Remains a Concern
One of the more lasting consequences of the pandemic is long COVID, a condition where symptoms persist for weeks or months after the initial infection. CDC survey data showed that prevalence among U.S. adults dropped from 7.5% in mid-2022 to 6.0% by mid-2023. That decline likely reflects a combination of time, treatment, and milder reinfections, but 6% of the adult population is still millions of people dealing with lingering fatigue, brain fog, shortness of breath, or other symptoms. Long COVID can follow even mild initial infections, which is one reason the virus continues to matter even when individual cases seem minor.
What “Endemic” Actually Means
You’ll often hear that COVID-19 has become “endemic,” and that’s broadly accurate, but the word is frequently misunderstood. Endemic doesn’t mean harmless or rare. It means the virus circulates at a relatively predictable, ongoing level rather than causing the explosive, unpredictable surges that define a pandemic. Malaria is endemic in many countries. So is the flu.
Reaching true endemic status requires several things working at once: high population immunity with at-risk groups adequately protected, health systems capable of absorbing periodic surges without disrupting other care, robust surveillance and sequencing to catch new variants early, and ongoing production of updated vaccines and treatments. Most high-income countries have met these benchmarks to varying degrees, which is why daily life has largely returned to normal. But the infrastructure behind the scenes, including wastewater monitoring, variant tracking, and annual vaccine reformulation, exists precisely because the virus hasn’t gone away.
Testing on Your Own
Home rapid tests are still sold over the counter at pharmacies and online. One practical note: many people still have older test kits in their medicine cabinets. The FDA has extended the expiration dates on numerous home tests beyond what’s printed on the box. You can check whether your specific test is still valid by searching the FDA’s online table of at-home COVID-19 diagnostic tests, which lists each manufacturer and any extended dates. Insurance providers are no longer required to cover the cost of home tests, so you may pay out of pocket.
PCR tests, which are more accurate, are still available through clinics and labs. The CDC recommends PCR testing for people at higher risk of severe disease, since a reliable positive result is the fastest path to getting antiviral treatment started in time.